Leaflet DOPEGYT 250mg tablets


Indicated for: hypertension

Route of administration: oral

Substance: methyldopa (antihypertensive)

ATC: C02AB01 (Cardiovascular system | Antiadrenergic agents, centrally acting | Methyldopa)

Methyldopa is an antihypertensive medication primarily used to treat high blood pressure, especially during pregnancy, due to its safety profile for both the mother and the fetus. It works on the central nervous system to lower blood pressure by reducing the activity of the sympathetic nervous system.

Methyldopa is converted in the body into an active compound that stimulates alpha-2 adrenergic receptors in the brain, leading to the relaxation of blood vessels and a decrease in blood pressure. It is often used as a first-line treatment for hypertension in pregnancy.

Side effects may include drowsiness, fatigue, dizziness, dry mouth, headache, or fluid retention. In rare cases, it can cause depression, hemolytic anemia, or liver function impairment. It is important to take methyldopa as prescribed by a doctor, with regular monitoring to prevent adverse effects.

General data about DOPEGYT 250mg

  • Substance: methyldopa
  • Date of last drug list: 01-05-2026
  • Commercial code: W04208001
  • Concentration: 250mg
  • Pharmaceutical form: tablets
  • Quantity: 50
  • Product type: generic
  • Price: 37.29 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: EGIS PHARMACEUTICALS PLC - UNGARIA
  • Holder: EGIS PHARMACEUTICALS PLC - UNGARIA
  • Number: 9698/2017/01
  • Shelf life: 5 years

Compensation lists for DOPEGYT 250mg Egis

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

37.29 RON

33.56 RON

3.73 RON